Prechemotherapy cognitive function in 362 breast cancer (BC) patients and 362 age-paired controls without cancer: A nationwide longitudinal trial conducted through the University of Rochester Cancer Center (URCC) Community Clinical Oncology Program (CCOP) Research Base (RB).
Michelle C. Janelsins(University of Rochester), Gary R. Morrow(University of Rochester Medical Center), Mohamedtaki Abdulaziz Tejani(AdventHealth Orlando), Tim A. Ahles(Memorial Sloan Kettering Cancer Center), Mary Ontko(Dayton Clinical Oncology Program), Luke J. Peppone(University of Rochester Medical Center), Christine B. Ambrosone(Unknown), Supriya G. Mohile(University of Rochester Medical Center), Charles Kamen(University of Rochester), Marie Flannery(National Cancer Research Institute), Judith O. Hopkins(Novant Health), Karen M. Mustian(University of Rochester Medical Center), Charles E. Heckler(University of Rochester Medicine), Anita R. Peoples(University of Utah), Matthias Weiss, Steven Corso(Spartanburg Regional Medical Center), Oxana Palesh(Virginia Commonwealth University)
Cited by 0
Related Papers
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k
Cancer-Related Fatigue, Version 2.2015
|Journal of the National Comprehensive Cancer Network|2015|951
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue
|JAMA Oncology|2017|913
A Population-Based Study of Genes Previously Implicated in Breast Cancer
|New England Journal of Medicine|2021|862
Metabolic gene polymorphism frequencies in control populations.
|PubMed|2001|847